Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,525 USD | -2,90% | +2,72% | -13,38% |
11/03 | Sectorupdate: Aandelen gezondheidszorg eind van de middag zachter | MT |
11/03 | Sectorupdate: Gezondheidszorg | MT |
Omzet 2021 | 172 mln. 159 mln. | Omzet 2022 | 317 mln. 294 mln. | Marktkapitalisatie | 380 mln. 353 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -8 mln. -7,42 mln. | Nettowinst (verlies) 2022 | 35 mln. 32,48 mln. | EV/omzet 2021 | 3,44 x |
Nettoliquiditeiten 2021 | 67,84 mln. 62,95 mln. | Nettoschuld 2022 | 10,19 mln. 9,45 mln. | EV/omzet 2022 | 1,23 x |
K/w-verhouding 2021 |
-77
x | K/w-verhouding 2022 |
10,7
x | Werknemers | 134 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 65,14% |
Recentste transcriptie over Eagle Pharmaceuticals, Inc.
1 dag | -2,90% | ||
1 week | +2,72% | ||
Lopende maand | +10,76% | ||
1 maand | -3,62% | ||
3 maanden | -19,11% | ||
6 maanden | -51,13% | ||
Lopend jaar | -13,38% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 01-11-13 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Ryan Debski
CMP | Compliance Officer | - | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 28-08-19 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.54% | 0 M€ | -1,71% | ||
0.25% | 0 M€ | -3,15% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 4,53 | -2,79% | 74 340 |
09-05-24 | 4,66 | -1,89% | 51 642 |
08-05-24 | 4,75 | 0,00% | 69 831 |
07-05-24 | 4,75 | +3,94% | 83 278 |
06-05-24 | 4,57 | +3,63% | 167 853 |
uitgestelde koers Nasdaq, 10 mei 2024 om 19:27 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-13,38% | 60,52 mln. | |
+7,91% | 72,94 mld. | |
+12,64% | 9,06 mld. | |
-10,56% | 5,07 mld. | |
+58,79% | 4,78 mld. | |
+4,07% | 3,9 mld. | |
-16,90% | 2,56 mld. | |
+20,84% | 2,42 mld. | |
-26,13% | 2,39 mld. | |
+19,31% | 2,18 mld. |